+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 110Years
All Genders
ID05855031

The Liver Care Trial Testing Liver Disease Screening Using Liver Stiffness Measurement in Adults Receiving Treatment for Alcohol Use Disorder

Led by Zealand University Hospital · Updated on 2023-05-17

408

Participants Needed

2

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of screening for liver disease using liver stiffness measurement in individuals undergoing treatment for alcohol use disorder who do not have a history of liver disease. This randomized controlled trial compares two approaches to screening, aiming to see if the intervention influences abstinence or light alcohol consumption after six months. Participants are randomly assigned to one of two groups the intervention group receives an invitation for a liver stiffness measurement using transient elastography, blood sampling, and a leaflet about alcohol-related disease the control group receives an invitation for blood sampling with Fib-4 screening only. The liver stiffness measurement is performed once, 1 to 2 weeks after randomization. During the study, participants will be monitored for alcohol consumption, with the primary outcome being abstinence or light consumption 10 or fewer units per week assessed six months after randomization. Secondary measures include the number of heavy drinking days and changes in alcohol use scores. The trial involves outpatient participants receiving alcohol use disorder treatment, and participation lasts at least six months following randomization.

CONDITIONS

Brief Title

The Liver Care Trial

Research Team

P

Pernille Dahlin, MD

G

Gro Askgaard, PHD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here